Knee pain breakthrough? new cell therapy shows promise in early trial
NCT ID NCT06084988
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This early-stage study tested a new treatment called StromaForte for people with mild-to-moderate knee osteoarthritis. Twelve adults received a single injection of donor stem cells into the knee joint. The main goal was to check if the treatment is safe and tolerable over 24 weeks, while also looking at whether it reduces pain and improves knee function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEO ARTHRITIS KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Burjeel Medical City
Abu Dhabi, United Arab Emirates
Conditions
Explore the condition pages connected to this study.